What alternative options to mesh-based sacrocolpopexy are appropriate for a 60- to 70-year-old woman with moderate comorbidities?

Alternative Options to Mesh-Based Sacrocolpopexy

For a 60-70-year-old woman with moderate comorbidities, laparoscopic sacrohysteropexy (if uterus-preserving) or sacrocolpopexy using autologous fascia lata represents the most promising mesh-free alternative, with emerging evidence showing low recurrence rates and minimal donor site morbidity.

Primary Mesh-Free Alternatives

Autologous Tissue Grafts (Preferred)

Autologous fascia lata (AFL) and autologous rectus sheath (ARS) are the most viable mesh-free options based on current evidence 1. These approaches offer several advantages:

• Fascia lata can be harvested laparoscopically or robotically, allowing larger grafts (12 × 4 cm documented) with low donor site morbidity 2
• Compression bandaging for 4 weeks at harvest site is typically sufficient
• One-year follow-up data shows no prolapse recurrence in documented cases 2

The Bologna technique using Ti-Cron suture for mesh-free sacropexy demonstrates particularly strong outcomes. In a cohort of 81 patients, laparoscopic sacrohysteropexy (LSHP) showed significantly lower objective recurrence risk compared to cervicosacropexy 3. This technique involves:

• Anchoring Ti-Cron suture to the anterior longitudinal ligament of the sacrum
• Progressive plication of the right uterosacral ligament
• Tension-free suspension of the uterus, cervix, or vaginal vault

Non-Crosslinked Acellular Dermal Matrix (ADM)

Non-crosslinked ADM represents a reasonable alternative when autologous tissue is not feasible 4. In a series of 211 patients:

• 87.5% reported being "a little better" or "much better" postoperatively
• Reoperation rate was 4.76%
• Histology showed neovascularization and connective tissue formation without intense fibrosis
• However, this is inferior to autologous options and should be considered second-line

Important Caveats and Predictors

Risk Stratification

Advanced prolapse (POP-Q stage IV) is an independent predictor of recurrence regardless of surgical technique 3. For your 60-70-year-old patient with moderate comorbidities:

• Age ≥70 is NOT associated with increased perioperative adverse events, prolapse recurrence, or mesh complications 5
• Women ≥70 actually had 73% lower odds of surgical site infections
• Comorbidity burden (measured by CCI score) matters more than chronological age

Surgical Approach Selection Algorithm

1. If uterus present and patient desires preservation: Laparoscopic sacrohysteropexy with autologous fascia lata (lowest recurrence risk) 3, 2

2. If post-hysterectomy: Laparoscopic sacrocolpopexy with autologous fascia lata 1

3. If autologous tissue harvest contraindicated: Non-crosslinked ADM as second-line 4

4. Avoid: Crosslinked allografts and xenografts show reduced durability compared to mesh and have limited patient acceptability 1

Operative Considerations

Minimally invasive approaches (laparoscopic or robotic) are appropriate for this age group. Expected operative parameters with autologous fascia lata:

• Operative time: approximately 120 minutes 2
• Hospital stay: typically 2 days
• No perioperative complications in reported series

Common Pitfalls to Avoid

• Do not assume age alone contraindicates surgery - the safety profile for women ≥70 is excellent 5
• Avoid non-autologous biologic grafts (allografts/xenografts) as they show inferior durability 1
• Screen for advanced prolapse (stage IV) as this independently predicts recurrence regardless of technique 3
• Most common postoperative complaint is overactive bladder symptoms, followed by vaginal discharge - counsel patients preoperatively 4

The evidence strongly supports that mesh-free alternatives using autologous tissue are viable options, particularly given the ongoing regulatory concerns with synthetic mesh. Patient-reported outcomes significantly improve across all mesh-free approaches with reductions in POPDI-6, UDI-6, and PFDI-20 scores 3.